Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.

MLA

Nozzoli, Chiara, et al. “Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.” Transplantation and Cellular Therapy, vol. 31, no. 1, Jan. 2025, p. 26.e1-26.e13. EBSCOhost, https://doi.org/10.1016/j.jtct.2024.10.015.

APA

Nozzoli, C., Pucillo, M., Giaccone, L., Rambaldi, A., Stanghellini, M. T. L., Benedetti, E., Russo, D., Mordini, N., Mangiacavalli, S., Bernasconi, P., Parma, M., Carluccio, P., Galieni, P., Rivela, P., Martino, M., Chiusolo, P., Isola, M., De Martino, M., Oldani, E., … Patriarca, F. (2025). Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation. Transplantation and Cellular Therapy, 31(1), 26.e1-26.e13. https://doi.org/10.1016/j.jtct.2024.10.015

Chicago

Nozzoli, Chiara, Martina Pucillo, Luisa Giaccone, Alessandro Rambaldi, Maria Teresa Lupo Stanghellini, Edoardo Benedetti, Domenico Russo, et al. 2025. “Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.” Transplantation and Cellular Therapy 31 (1): 26.e1-26.e13. doi:10.1016/j.jtct.2024.10.015.